128 related articles for article (PubMed ID: 23406895)
1. Effectiveness of the ThinPrep Imaging System in the detection of abnormal cervicovaginal cytology: a practical experience in Korea.
Ha SY; Lee YK; Oh YL
Acta Cytol; 2013; 57(2):159-63. PubMed ID: 23406895
[TBL] [Abstract][Full Text] [Related]
2. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
Duby JM; DiFurio MJ
Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
[TBL] [Abstract][Full Text] [Related]
3. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
[TBL] [Abstract][Full Text] [Related]
4. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
Zhao C; Zhao S; Heider A; Austin RM
Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
[TBL] [Abstract][Full Text] [Related]
5. Cervical cytology of atypical squamous cells, cannot exclude high-grade squamous intra-epithelial lesion: significance of age, human papillomavirus DNA detection and previous abnormal cytology on follow-up outcomes.
Sung CO; Oh YL; Song SY
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):155-9. PubMed ID: 21683502
[TBL] [Abstract][Full Text] [Related]
6. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
7. [Application of high-risk human papillomavirus testing in women with abnormal cytology].
Ou H; Bian ML; Zhang XY; Chen QY; Li M; Chen Y; Liu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):608-11. PubMed ID: 18051714
[TBL] [Abstract][Full Text] [Related]
8. [Triage value of high risk human papilloma virus detection in women with abnormal cervical cytology].
Jin Y; Pan LY; Wang YF; Cheng XM; Lang JH
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1173-6. PubMed ID: 18844110
[TBL] [Abstract][Full Text] [Related]
9. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
[TBL] [Abstract][Full Text] [Related]
10. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
11. Cervical cytological screening and management in pregnant and postpartum women.
He GF; Bian ML; Wang Y; Liu XY
Chin Med Sci J; 2005 Dec; 20(4):242-6. PubMed ID: 16422252
[TBL] [Abstract][Full Text] [Related]
12. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
[No Abstract] [Full Text] [Related]
13. Should LSIL-H be a distinct cytology category?: A study on the frequency and distribution of 40 human papillomavirus genotypes in 808 women.
Zhou H; Schwartz MR; Coffey D; Smith D; Mody DR; Ge Y
Cancer Cytopathol; 2012 Dec; 120(6):373-9. PubMed ID: 22648956
[TBL] [Abstract][Full Text] [Related]
14. Off-label high-risk HPV DNA testing of vaginal ASC-US and LSIL cytologic abnormalities at Parkland hospital.
Chappell CA; West AM; Kabbani W; Werner CL
J Low Genit Tract Dis; 2010 Oct; 14(4):352-5. PubMed ID: 20885164
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the ThinPrep Imaging System: clinical experience in a low risk screening population.
Papillo JL; St John TL; Leiman G
Diagn Cytopathol; 2008 Mar; 36(3):155-60. PubMed ID: 18232005
[TBL] [Abstract][Full Text] [Related]
16. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
17. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia.
Holladay EB; Logan S; Arnold J; Knesel B; Smith GD
Cancer; 2006 Dec; 108(6):451-61. PubMed ID: 17078096
[TBL] [Abstract][Full Text] [Related]
18. The use of p16(INK4A) immunocytochemistry in "Atypical squamous cells which cannot exclude HSIL" compared with "Atypical squamous cells of undetermined significance" in liquid-based cervical smears.
Sung CO; Kim SR; Oh YL; Song SY
Diagn Cytopathol; 2010 Mar; 38(3):168-71. PubMed ID: 19760769
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical detection of raf kinase inhibitor protein and human papillomavirus profiling of normal and abnormal cervical ThinPrep samples.
Al-Awadhi R; Husain S; Chehadeh W; Al-Jassar W; Kapila K; Al-Mulla F
Acta Cytol; 2013; 57(3):259-65. PubMed ID: 23636063
[TBL] [Abstract][Full Text] [Related]
20. [Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].
Guo YL; You K; Geng L; Zhang XW; Shen XY; Yao YJ; Fan XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):480-2. PubMed ID: 17068618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
